Search Results - pulmonology+pharma

1 Results

Sort By:

Novel Pharmaceutical for Prevention of Bleomycin-Induced Pulmonary Fibrosis

Reference #: 01409 The University of South Carolina is offering licensing opportunities for Novel Pharmaceutical for Prevention of Bleomycin-Induced Pulmonary Fibrosis Background: Hodgkin’s lymphoma is one of the curable cancers and the standard treatment regimen involves combination chemotherapy involving bleomycin. One of the fatal side effects...

Published: 9/4/2022 | Inventor(s): Michael Wyatt, Chloe LeBegue

Keywords(s): bleomycin, bleomycin hydrolase, enzyme, inhaled, protein, pulmonary fibrosis, pulmonary toxicity, pulmonology biotech, pulmonology pharma

Category(s): Chemistry and Biochemistry, Health Sciences